secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2026-05-29T21:00:24+00:00
Accession:  0001493152-26-026414
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Scienture CFO Eric Sherb resigns; co-CEO Narasimhan Mani named interim CFO
--------------------------------------------------------------------------

- Eric Sherb resigned as CFO effective May 26, 2026; cited personal reasons, no disagreement with management or board.
- Dr. Narasimhan Mani appointed Interim CFO same day; Mani also serves as co-CEO, President, and director.
- Mani holds an MBA in Finance from Columbia Business School and has 25+ years in pharma leadership roles.
- No material transaction or family relationship between Mani and the company; employment governed by existing agreement.
- Mani previously served as CEO of Kesin Pharma and Xiromed, and VP strategy at Amneal Pharmaceuticals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/0001493152-26-026414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315226026414/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-026414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer